Beeline Medicines
beelinemedicines.com
Actively hiring
Immunology & Inflammation Therapeutics
Drug Discovery
View 17 jobs
Claim pageClaim
Follow
Overview
Connections
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Total raised
$426.3M
1 round on record
Latest round
$426.3M
Series A · Jun 2026 · 4 mo ago
Team
201-500
employees, estimated range
Hiring now
27
+9 posted in 30 days
The money's age
Fresh money
4 months since the last round · and hiring
Momentum
58/100
hiring for its size, a new city, in the news, fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jun 30
Raised a round Series A $426.3M · YahooFinance
Apr 15
Launched Beeline Medicines Debuts to Deliver Category-Leading Precision Therapies for People Living with Autoimmune and Inflammatory Diseases · manilatimes.net
Apr 2026
Website went live first capture in the Wayback Machine
Tractionpublic signals, read monthly
Web presence
top 11%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series A | Jun 2026 | $426.3M | — | YahooFinance |
Investors in similar startupsfunds that back the companies most like this one
backs Quell Therapeutics Ltd
Similar startupsby what they do, their industry and backers
Dianthus Therapeutics is a clinical-stage biotechnology company developing therapies for patients living with severe autoimmune diseases…
A biotech company developing better medicines for patients with autoimmune and inflammatory diseases. Leveraging powerful insights into the…
Quell Therapeutics is a clinical-stage company, fuelled by curiosity and discovery, on a mission to make life better for those battling…
Mirador Therapeutics is a clinical-stage precision medicine company developing therapies for immune-mediated inflammatory and fibrotic…
Coultreon Biopharma is a clinical-stage biotech company developing next-generation precision medicines for immunology and autoimmune…
Company Management Team Board of Directors Scientific Advisory Board Clinical Advisory Board Company History Investors Science Biology…
Overview
Beeline Medicines is a clinical-stage biotechnology company developing precision therapies for autoimmune and inflammatory diseases, with offices in Stamford, Connecticut, and Cambridge, Massachusetts. Its portfolio consists of therapeutic candidates that target key pathways driving dysregulated immune and inflammatory responses, and the company is backed by life science investors. It hires across medical affairs, regulatory strategy, clinical pharmacology, biostatistics, clinical data management, pharmacovigilance, medical writing and contracts, as well as medical science liaisons and clinical engagement leads in India, China, Mexico, Brazil and Argentina.
News
Beeline Medicines Announces Positive Topline Results from Global Phase 2 Study of Afimetoran in Systemic Lupus Erythematosus
- Study met its primary endpoint, with afimetoran demonstrating higher SRI-4 response rates versus placebo at Week 48 (p-value 0.001 across al...
Read more
Report
Beeline Medicines Raises $426.3 Million Series A To Advance Autoimmune And Inflammatory Disease Portfolio
Beeline Medicines announced the closing of a $126.3 million Series A extension. The new funding brings the company's total Series A financing round to $426.3 million. The extension adds to Beeline Medicines' previously announced $300 million Series A fina
Read more
Report
Beeline Medicines Announces Upsized Series A of $426.3 Million to Advance Category-Leading Autoimmune and Inflammatory Disease Portfolio
- $126.3 million of new funding adds to previously announced $300 million Series A financing - - Proceeds will support advancement of afimetoran into pivotal development for lupus and clinical study initiations for multiple development candidates over the
Read more
Report
CPP Investments participates in Beeline Medicines' upsized US$426.3 million Series A financing
On June 30, 2026, Beeline Medicines Corporation announced the closing of a 126.3 million dollar Series A extension, bringing its total Series A financing round to 426.3 million dollars. The extension builds on Beeline Medicines' previously announced 300 m
Read more
Report
Beeline Medicines: $300 Million Series A Launches Precision Immunology Biotech With Broad Pipeline
Beeline Medicines officially launched with $300 million in Series A financing led by Bain Capital, positioning the company to develop next-generation precision therapies for autoimmune and inflammatory diseases.
Read more
Report
Beeline Medicines Debuts to Deliver Category-Leading Precision Therapies for People Living with Autoimmune and Inflammatory Diseases
Read more
Report
Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immunology Therapies that Address the Unmet Medical Needs of Patients
The post Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immunology Therapies that Address the Unmet Medical Needs of Patients appeared first on Beeline Medicines.
Read more
Report
Tech stack
Technologies named in job postings at Beeline Medicines over the last 12 months, by layer, with the share of postings for each.
Technologies in use
21
Postings analysed
33
Stack modernity
57/100
Languages
SAS9%
Cloud & platforms
GCP42%
Microsoft Entra ID6%
Power BI6%
Windows3%
Sign in to see how your skills match this stack
Sign In
Full Beeline Medicines tech stack
21 technologies · by team · pay by technology · changes · similar stacks
Salary insights
Compensation ranges based on this company's open jobs
Median
$235k
Typical range
$100k – $382k
Open positions
21
20
Jobs
Middle
5%
Senior
40%
Staff
10%
Architect
45%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Middle | 1 | $100k | $100k |
| Senior | 8 | $314k | $146k – $345k |
| Staff | 2 | $207k | $100k – $313k |
| Architect | 9 | $235k | $174k – $382k |
Highest paying role
Vice President, Medical Affairs
$382k
Normalized to USD per year
All salaries at Beeline Medicines
By role, level and city, against the market · 21 jobs with pay
Growth
Hiring Momentum
53/100
Stable
Open positions
27
4 opened / 1 closed in 30 days
Median time-to-fill
35 days
faster than 37% of the market
ATS activity
Every ~4 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Biotech
29% ▲
Science & Research
26% ▼
Early Careers
19% ▼
Operations
7%
Support
5% ▲
Administrative
2% ▲
Actively hiring for Biotech (+3 in 30 days)
Activity Timeline
New location: Durham
Oct 2026
Added GMP to stack
Oct 2026
Added Design of Experiments to stack
Oct 2026
Added CAPA to stack
Oct 2026
Added Medidata Rave to stack
Oct 2026
Added Good Clinical Practice to stack
Oct 2026
Added 21 CFR Part 11 to stack
Oct 2026
Added Veeva to stack
Oct 2026
Added ICH Guidelines to stack
Oct 2026
Added CDISC to stack
Oct 2026
Added VPN to stack
Oct 2026
Added ServiceNow to stack
Oct 2026
Offices
Where the company hires and what each office is for
Cities
4
Hiring now
3
Countries
2
Busiest office
Stamford
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Stamford
United States
HQ
Stamford, CT Office
2 open roles 3 posted in 90 days 50-200 est. staff $157k Avg Salary
hires for Finance
Cambridge
United States
Regional office
Cambridge, MA Office
11 open roles 11 posted in 90 days 50-200 est. staff $255k Avg Salary
hires for Biotech, Early Careers, Support
Durham
United States
Regional office
Durham, NC Office
2 open roles 2 posted in 90 days 10-50 est. staff $209k Avg Salary
hires for Operations, Biotech
Singapore
Singapore
Regional office
Singapore
Earlier presence
Boston, United States
Jobs
$266k – $344k per year · Hybrid · 2+ years exp · United States
Apply
$165k – $215k per year · Hybrid · Bachelor's Degree · Cambridge
Veeva
Apply
$77k – $100k per year · Hybrid · Full-Time · 3+ years exp · Bachelor's Degree · Cambridge
DNS
VPN
Wi-Fi
Cybersecurity
Microsoft Entra ID
Management
Jira
ServiceNow
SharePoint
ITSM
Service Desk
Apply
$181k – $235k per year · Hybrid · 7+ years exp · Bachelor's Degree · United States
GCP
Cybersecurity
GDPR
HIPAA
Life Sciences
ICH Guidelines
CDISC
Veeva
Medidata Rave
Apply
$199k – $258k per year · Hybrid · 10+ years exp · PhD · Durham
GMP
ICH Guidelines
Design of Experiments
Apply
Apply
$293k – $345k per year · Hybrid · 5+ years exp · Master's Degree · Cambridge
Apply
$199k – $258k per year · Hybrid · 10+ years exp · Master's Degree · United States
ICH Guidelines
Veeva
Apply
$242k – $313k per year · Hybrid · 12+ years exp · Master's Degree · United States
ICH Guidelines
Apply
$242k – $314k per year · Hybrid · 12+ years exp · PhD · Cambridge
ICH Guidelines
Apply
$242k – $314k per year · Hybrid · 12+ years exp · PhD · Cambridge
ICH Guidelines
Apply
$266k – $344k per year · Hybrid · 3+ years exp · Bachelor's Degree · Cambridge
GCP
Life Sciences
Good Clinical Practice
ICH Guidelines
Veeva
MedTech
21 CFR Part 11
CAPA
Apply
Financials
Total raised
$426.3M
Latest round
Series A
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series A | 2026 | $426.3M | Details |